Cargando…
Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects
This review aims to synthesize the most updated research, outcomes, and trends in the field of pediatric liver transplantation (LT), specifically focusing on children who have suffered from acute liver failure. Pediatric acute liver failure is a dynamic, life‐threatening condition that can either se...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588650/ https://www.ncbi.nlm.nih.gov/pubmed/35557028 http://dx.doi.org/10.1002/lt.26500 |
_version_ | 1784814147158933504 |
---|---|
author | Ascher Bartlett, Johanna M. Yanni, George Kwon, Yong Emamaullee, Juliet |
author_facet | Ascher Bartlett, Johanna M. Yanni, George Kwon, Yong Emamaullee, Juliet |
author_sort | Ascher Bartlett, Johanna M. |
collection | PubMed |
description | This review aims to synthesize the most updated research, outcomes, and trends in the field of pediatric liver transplantation (LT), specifically focusing on children who have suffered from acute liver failure. Pediatric acute liver failure is a dynamic, life‐threatening condition that can either self‐resolve or lead to death. LT is a lifesaving intervention. With the introduction of technical variant grafts and recent immunosuppression modifications, overall patient survival, graft survival, and waitlist mortality have improved. Furthermore, recent advances in the knowledge of immunologic mediators of acute liver failure offer the possibility of more detailed understanding of the pathophysiology and new areas for research. Given the success of living donor LT for pediatric patients with acute liver failure, this option should continue to be actively considered as an alternative treatment option for patients who are listed for transplantation and are managed at a multidisciplinary tertiary care transplant center. |
format | Online Article Text |
id | pubmed-9588650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95886502022-12-30 Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects Ascher Bartlett, Johanna M. Yanni, George Kwon, Yong Emamaullee, Juliet Liver Transpl Review Articles and Practice‐based Recommendations This review aims to synthesize the most updated research, outcomes, and trends in the field of pediatric liver transplantation (LT), specifically focusing on children who have suffered from acute liver failure. Pediatric acute liver failure is a dynamic, life‐threatening condition that can either self‐resolve or lead to death. LT is a lifesaving intervention. With the introduction of technical variant grafts and recent immunosuppression modifications, overall patient survival, graft survival, and waitlist mortality have improved. Furthermore, recent advances in the knowledge of immunologic mediators of acute liver failure offer the possibility of more detailed understanding of the pathophysiology and new areas for research. Given the success of living donor LT for pediatric patients with acute liver failure, this option should continue to be actively considered as an alternative treatment option for patients who are listed for transplantation and are managed at a multidisciplinary tertiary care transplant center. John Wiley and Sons Inc. 2022-05-27 2022-11 /pmc/articles/PMC9588650/ /pubmed/35557028 http://dx.doi.org/10.1002/lt.26500 Text en © 2022 The Authors. Liver Transplantation published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Review Articles and Practice‐based Recommendations Ascher Bartlett, Johanna M. Yanni, George Kwon, Yong Emamaullee, Juliet Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects |
title | Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects |
title_full | Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects |
title_fullStr | Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects |
title_full_unstemmed | Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects |
title_short | Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects |
title_sort | pediatric acute liver failure: reexamining key clinical features, current management, and research prospects |
topic | Review Articles and Practice‐based Recommendations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588650/ https://www.ncbi.nlm.nih.gov/pubmed/35557028 http://dx.doi.org/10.1002/lt.26500 |
work_keys_str_mv | AT ascherbartlettjohannam pediatricacuteliverfailurereexaminingkeyclinicalfeaturescurrentmanagementandresearchprospects AT yannigeorge pediatricacuteliverfailurereexaminingkeyclinicalfeaturescurrentmanagementandresearchprospects AT kwonyong pediatricacuteliverfailurereexaminingkeyclinicalfeaturescurrentmanagementandresearchprospects AT emamaulleejuliet pediatricacuteliverfailurereexaminingkeyclinicalfeaturescurrentmanagementandresearchprospects |